Pancreatic Cancer Research

ResearcherFirst People's Hospital of XianyangNo recent work listed

Yongcun Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4098-4732; OpenAlex author ID A5027677425. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers

Papers 3

  1. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression. Co-author DOI 10.1002/cbf.3449↗
  2. LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway. First author DOI 10.1186/s12935-020-01366-w↗
  3. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling. First author DOI 10.1016/j.cbi.2019.02.026↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liping Wu · 2 shared papers, 2020 · strength 0.32
  2. Cheng Guo Ma · 2 shared papers, 2020 · strength 0.32
  3. Yuan Shao · 1 shared paper, 2020 · strength 0.16
  4. Enxiao Li · 1 shared paper, 2019 · strength 0.11
  5. Li Feng · 1 shared paper, 2019 · strength 0.11
  6. Jing Liang · 1 shared paper, 2019 · strength 0.11
  7. Lei Zhang · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.